
READ HERE
Prevalence and risk factors for uveitis in spondyloarthritis
Yasmin, MR, Islam, MN, Pannu, ZR, Azad, MAK, Uddin, MSG. Prevalence and risk factors for uveitis in spondyloarthritis. Int J Rheum Dis. 2022; 25: 517– 522. doi:10.1111/1756-185X.14303
Aim: To determine the prevalence and risk factors for uveitis in spondyloarthritis (SpA) patients.
Results: Prevalence of uveitis was 18.7%. The disease duration was 9.3 ± 7 years and 5.4 ± 4.5 years in uveitis and no uveitis groups respectively (P ≤ .001). Family history of SpA was positive in 45.2% in the uveitis group (P ≤ .001). The frequency of axial SpA was 92.9% and 73.8% in the uveitis and no uveitis groups respectively (P ≤ .008). The mean BASDAI was 2.4 ± 1.9 and 3.3 ± 2.8 in uveitis and no uveitis groups respectively (P = .050). In multivariate logistic regression analysis, among the selected variables, family history of SpA (odds ratio [OR] =3.697; 95% CI =1.616-8.457; P = .002) and duration of disease (OR =1.089; 95% CI =1.004-1.181; P = .039) were independently associated with the occurrence of uveitis.
Conclusions: The prevalence of uveitis was 18.7%. The family history and the disease duration of SpA were independently associated with uveitis.